Products

Our products

Learn more about our product portfolio and how we’re prioritising specialty medicines and vaccines.

Our product areas Products A-Z

Close video

Scroll to explore

Our product areas

Specialty medicines

Vaccines

Escherichia Coli (E. Coli) Bacteria Science Image

General medicines

View our product areas

Our medicines and vaccines

Getting ahead means preventing disease as well as treating it. Our R&D focus is to deliver new medicines and vaccines using the science of the immune system and advanced technologies to impact health at scale.

Medicine and vaccine manufacturing sites in our global network

1.64bn

Packs of medicines delivered in 2025

389m

Vaccine doses delivered in 2025

100

Our general medicines reach people in more than 100 countries

Behind the Science

Exploring how today's discoveries are shaping tomorrow's health

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment

Mapping disease at the cellular level: A single-cell revolution in drug discovery

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

Read our magazine